Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.02.2020 | Case report

Influenza-virus-vaccine

Various toxicities: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Panatto D, et al. Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59-adjuvanted influenza vaccine in older adults: Results from three consecutive seasons. Influenza and other Respiratory Viruses 14: 61-66, No. 1, Jan 2020. Available from: URL: http://doi.org/10.1111/irv.12685 CrossRef Panatto D, et al. Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59-adjuvanted influenza vaccine in older adults: Results from three consecutive seasons. Influenza and other Respiratory Viruses 14: 61-66, No. 1, Jan 2020. Available from: URL: http://​doi.​org/​10.​1111/​irv.​12685 CrossRef
Metadaten
Titel
Influenza-virus-vaccine
Various toxicities: 2 case reports
Publikationsdatum
01.02.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-74989-0

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Mepolizumab

Case report

Sildenafil

Case report

Cisplatin

Case report

Valproic-acid